TODAY, MEASURES TO PREVENT HEPATITIS D DISEASE

Main Article Content

Esonova Orzigul Shamshiddinovna

Abstract

Hepatitis D, also known as Hepatitis Delta, is a serious liver infection caused by the Hepatitis D virus (HDV). It is a satellite virus that requires the presence of Hepatitis B virus (HBV) to replicate. Prevention of Hepatitis D is closely tied to controlling Hepatitis B infection through vaccination, public health education, and targeted prevention strategies. This article explores key preventive measures against Hepatitis D, reviewing the latest literature, methodologies for prevention, and the significance of vaccination in controlling this disease.

Article Details

How to Cite
Esonova Orzigul Shamshiddinovna. (2024). TODAY, MEASURES TO PREVENT HEPATITIS D DISEASE. Galaxy International Interdisciplinary Research Journal, 12(10), 85–87. Retrieved from https://internationaljournals.co.in/index.php/giirj/article/view/5921
Section
Articles

References

The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 2008; 80(2): 277–82. 1. Wedemeyer HM, Michael. Epidemiology, pathogenesis and managementof hepatitis D: update and challenges ahead. Nature Review Gastroenterology and hepatology 2010; 7: 31–40.

Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet 2011; 378(9785): 73–85.

Rizzetto M Hepatitis D: Thirty years after. Journal of Hepatology 2009; 50(5): 1043–50

Chen HY, Shen DT, Ji DZ, et al. Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut 2018; 68: 512–21. •• This systematic review and metaanalysis found that the prevalence of HDV among HBsAg-positive individuals may be higher than was previously reported.

Rizzetto M Hepatitis D virus: introduction and epidemiology. Cold Spring Harb Perspect Med 2015; 5(7): a021576. 24. Rizzetto M, Canese MG, Aricò S, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977; 18(12): 997–1003.

Da B.L., Heller Th., Koh Ch. (2019) Hepatitis D infection: from initial discovery to current investigational therapies. Gastroenterology Report, June 23, goz023.

Taylor JM. Hepatitis delta virus. Virology 2006; 344: 71– 6.